Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 20, 2017
Pharmacy Choice - News - Front Page Healthcare News - October 20, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/20/17 - "A Pharmaceutical Composition for the Treatment of Multi-Drug Resistant Infections" in Patent Application Approval Process (USPTO 20170273939)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors VISHWAKARMA, Ram; KUMAR, Ajay; KHAN, Inshad Ali; BHARATE, Sandip Bibishan; JOSHI, Prashant; SINGH, Samsher; SATTI, Naresh, filed on October 21, 2015, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., b
10/20/17 - "Pharmaceutical Composition for Topical Administration" in Patent Application Approval Process (USPTO 20170273945)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors LIU, Wai Leung; PURKINS, Lynn; YEADON, Michael, filed on June 9, 2017, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a com
10/20/17 - 1st Clinical 7-Tesla MRI Scanner in North America Will Enable Mayo Clinic to Achieve Higher-Resolution Imaging for Patients
Mayo Clinic issued the following news release:. Mayo Clinic will have the first clinical 7- Tesla MRI scanner in North America that has been cleared by the U.S. Food and Drug Administration. Mayo Clinic will be the first medical center in North America to offer patients advanced diagnostic imaging using an MRI scanner with the strongest magnetic fi
10/20/17 - 2017 DrugDev Summit, Co-Chaired by Novartis and CSL Behring, to Convene 100+ Clinical Leaders to Improve the Clinical Trial Experience for Patients, Sites and Study Teams [Sport360]
-The worlds most progressive pharmaceutical companies, CROs and sites will continue to advance beyond the clinical trial status quo at the 2017 DrugDev Summit in Philadelphia, November 7-8. Co-chaired by Novartis and CSL Behring, DrugDevs annual Summit is widely regarded by customers as the premier open forum for sharing clinical trial best practic
10/20/17 - 65 Acquisition of Medical Surgical Prime Vendor (MSPV) Supplies
Office Address: U.S. Department of Veterans Affairs; Office of Acquisition Operations; Strategic Acquisition Center; 10300 Spotsylvania Ave| STE 400; Fredericksburg VA 22408-2697. Subject: 65 Acquisition of Medical Surgical Prime Vendor Supplies. 10300 Spotsylvania Ave, Suite 400.
10/20/17 - A Chance To End Health Care Chaos [Qatar Tribune]
PRESIDENT Donald Trump and Republicans in Congress have brought chaos to the US health care system by trying to destroy the Affordable Care Act and failing to reauthorise the Children's Health Insurance Program, which, with bipartisan support for the past 20 years, has provided care for millions of children. In an ideal world, Congress would quickl
10/20/17 - Abbott Reports Third Quarter 2017 Results
Excluding specified items, adjusted diluted EPS from continuing operations was $0.66 in the third quarter, at the high end of the previous guidance range of $0.64 to $0.66. In September, Abbott received U.S. FDA approval for its FreeStyle Libre glucose monitoring system as a replacement1 for finger stick blood glucose monitoring. During the quarter
10/20/17 - AcelRx's DSUVIA? Clinical Trial Results Selected as a "Top Abstract" for Oral Presentation at ASA's Annual Meeting - ANESTHESIOLOGY 2017
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical, today announced its clinical data presentation on the safety and efficacy of DSUVIA?, 30 mcg classified by age group across four clinical trials at the American Society of Anesthesiologists' ANESTHESIOLOGY 2017 Annual Meeting. The information presented during the session was authored
10/20/17 - ADM Tronics Prepares New Respiratory Therapy Device for Market
By a News Reporter-Staff News Editor at Health& Medicine Week ADM Tronics Unlimited, Inc. is in the final stage of developing the Alvio? device, a new technology it has had under development pursuant to its previously announced agreement with QOL Devices, Inc.. "It is exciting to see the Alvio approaching commercialization," stated Bez Arkush,
10/20/17 - Alaska Dispatch News, Anchorage, Charles Wohlforth column [Alaska Dispatch News, Anchorage]
Oct. 20 The U.S. Senate battle over Obamacare repeal put Alaska Gov. Walker instead took a planned trip to China for meetings on his Alaska natural gas pipeline project. But the governor sent a team of seven to work with the White House to assess the impact of the bill on Alaska.
10/20/17 - Alnylam and Collaborators to Present APOLLO Phase 3 Study Results at 1st European ATTR Amyloidosis Meeting for Patients and Doctors
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the results of the APOLLO Phase 3 study of patisiran in hereditary ATTR amyloidosis patients with polyneuropathy, as well as additional posters on patisiran and hATTR amyloidosis, will be presented at the 1 st European ATTR Amyloidosis Meeting for Patients an
10/20/17 - Alnylam and Vir Form Strategic Alliance to Advance RNAi Therapeutics for Infectious Diseases
CAMBRIDGE, Mass.- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced an exclusive licensing agreement with Vir Biotechnology, a company dedicated to transforming the care of people with serious infectious diseases, for the development and commercialization of RNAi therapeutics for infectious diseases, including...
10/20/17 - Anemia Prevalence Promotes Growth Of Hematology Drugs Market
The market leader is Danish company Novo Nordisk, followed by the UK' s Shire and Germany' s Bayer. One of the trends shaping the market is an increase in product approvals for hemophilia. The increase in the number of drug approvals for hemophilia by the regulatory bodies such as FDA in the US is an emerging trend in the market. For instance, in J
10/20/17 - Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines [Tehran Times (Iran)]
-Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson& Johnson. The deal was facilitated by the Johnson& Johnson Innovation center, in California.
10/20/17 - Asia-Pacific Medical Suction Device Market Exorbitant Growth At CAGR 7% Expected Forecasts to 2023
Asia-Pacific Medical Suction Device, by Types by Usage, by Suction parts- Forecast to 2023. Executive Summary Market Research Future published new report, titled "Medical Suction Device Market- Research Report: Asia and Pacific Forecast to 2023". Market Synopsis ofMedical Suction Device Market: Market Scenario:.
10/20/17 - AstraZeneca - US FDA accepts regulatory submission for Lynparza in metastatic breast cancer and grants Priority Review
AstraZeneca and Merck& Co., Inc., today announced that the US Food and Drug Administration has accepted and granted Priority Review for a supplemental New Drug Application for the use of Lynparza tablets in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuva
10/20/17 - AstraZeneca - US FDA accepts supplemental Biologics License Application for Imfinzi in locally advanced unresectable non-small cell lung cancer
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Imfinzi for the treatment of patients with locally advanced unresectable non-small cell lung cancer whose disease has not progressed following platinum..
10/20/17 - Atara Biotherapeutics Initiates 60 Patient, Global Phase 1 Clinical Study to Evaluate Allogeneic ATA188 in Patients with Progressive or Relapsing-Remitting Multiple Sclerosis (MS) [Syrian Arab News Agency]
Atara Biotherapeutics, Inc., a leading "off-the-shelf", or allogeneic, T-cell immunotherapy company developing novel treatments for patients with cancer and autoimmune diseases, announced today that the Company initiated a multinational, multicenter Phase 1 clinical study to evaluate allogeneic ATA188 in patients with progressive or...
10/20/17 - AtriCure to Present at the Stifel Healthcare Conference
AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Stifel Healthcare Conference at the Palace Hotel in New York on Tuesday, November 14, 2017. AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditi
10/20/17 - Autosamplers Market Worth 1136.2 Million USD by 2022
According to a new market research report " Autosamplers Market by Product (Systems (Liquid Chromatography, GC (Liquid, Headspace, All-in-one)), Accessories (Syringe& Needle, Vial, Septum)& Enduser (Pharmaceutical companies, Oil& Gas, Food& Beverage, Environment testing)- Global Forecasts to 2022", published by MarketsandMarkets?, the market is p
10/20/17 - B. Braun To Showcase New Additions to Its Regional Anesthesia Portfolio at American Society of Anesthesiologists Annual Meeting
B. Braun Medical Inc. will present its expanding portfolio of regional anesthesia products at ANESTHESIOLOGY 2017, the American Society of Anesthesiologists Annual Meeting, Oct. 21-23, in Boston. New products designed to improve efficiency and patient outcomes will be showcased, including: Xperius Ultrasound System; SAXA Anesthesia Disinfectio
10/20/17 - Bharat Book Bureau: Global Electrodes for Medical Devices Market Professional Survey Report 2017
This report studies Electrodes for Medical Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.. This report focuses on top manufacturers in global market, with production, price, reve
10/20/17 - Bharat Book Bureau: Global Orthopedic Prosthetic Implants Market Professional Survey Report 2017
This report studies Orthopedic Prosthetic Implants in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.. This report focuses on top manufacturers in global market, with production, price, reve
10/20/17 - BioLife Solutions Customer Kite Pharma Receives FDA Approval for Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy [T-break Tech (Middle East)]
BioLife Solutions, Inc., the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, today announced that its customer Kite Pharma, Inc., a wholly-owned subsidiary of Gilead Sciences, has received US FDA approval for Yescarta, the first CAR T-cell therapy for.
10/20/17 - Breaking ObamaCare gridlock
For seven years, congressional Republicans and Democrats battling over ObamaCare have agreed on only one thing: They couldn't agree on anything. As insurers narrowed networks of doctors and hospitals or abandoned states entirely, Congress flailed. Five days after Trump's declaration- a blink of an eye in Congress- time- Republican Sen.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415